Insilico Medicine announces Nature Medicine publication of Phase IIa results evaluating rentosertib, the novel TNIK inhibitor for idiopathic pulmonary fibrosis (IPF) discovered and designed with a pioneering AI approach - EurekAlert!
From fibrosis and cancer to obesity, Alzheimer's and aging: New paper reveals broad potential of TNIK as a therapeutic ... - EurekAlert
